1. Home
  2. NCRA vs BRTX Comparison

NCRA vs BRTX Comparison

Compare NCRA & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nocera Inc.

NCRA

Nocera Inc.

N/A

Current Price

$1.87

Market Cap

3.1M

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

N/A

Current Price

$2.64

Market Cap

5.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCRA
BRTX
Founded
2002
1997
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Managed Health Care
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
5.4M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
NCRA
BRTX
Price
$1.87
$2.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.6M
250.9K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,627,944.00
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.14
52 Week High
$3.98
$4.10

Technical Indicators

Market Signals
Indicator
NCRA
BRTX
Relative Strength Index (RSI) 52.34 63.20
Support Level $0.18 $0.45
Resistance Level $2.59 $4.10
Average True Range (ATR) 0.25 0.38
MACD -0.00 0.22
Stochastic Oscillator 20.45 64.48

Price Performance

Historical Comparison
NCRA
BRTX

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: